Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
The Journal of Allergy and Clinical Immunology|November 30, 2020
Bone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell functionTommaso Sconocchia, Mathias Hochgerner, Elke Schwarzenberger, et al.
Antioxidants (Basel, Switzerland)|July 27, 2022
Immunomodulatory Effects of Aronia Juice Polyphenols-Results of a Randomized Placebo-Controlled Human Intervention Study and Cell Culture ExperimentsSonja Lackner, Tommaso Sconocchia, Tobias Ziegler, et al.
International Journal of Cancer|August 10, 2019
CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximabRoberto Arriga, Sara Caratelli, Giulia Lanzilli, et al.
Leukemia|February 22, 2023
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilitiesJohannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, et al.
Cell Reports|April 28, 2021
The miR-424(322)/503 gene cluster regulates pro- versus anti-inflammatory skin DC subset differentiation by modulating TGF-β signalingVictoria Zyulina, Koon-Kiu Yan, Bensheng Ju, et al.
International Journal of Cancer|September 4, 2019
In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumabSara Caratelli, Roberto Arriga, Tommaso Sconocchia, et al.
Oncotarget|December 15, 2015
Enhancement of anti-leukemia activity of NK cells in vitro and in vivo by inhibition of leukemia cell-induced NK cell damageRoberto Arriga, Sara Caratelli, Andrea Coppola, et al.
The Journal of Allergy and Clinical Immunology|December 25, 2019
BMP7 aberrantly induced in the psoriatic epidermis instructs inflammation-associated Langerhans cellsIzabela Borek, René Köffel, Julia Feichtinger, et al.
Experimental Hematology & Oncology|February 18, 2025
The CD64/CD28/CD3ζ chimeric receptor reprograms T-cell metabolism and promotes T-cell persistence and immune functions while triggering antibody-independent and antibody-dependent cytotoxicitySara Caratelli, Francesca De Paolis, Domenico Alessandro Silvestris, et al.
Life Science Alliance|October 14, 2022
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatmentGiuseppe Sconocchia, Giulia Lanzilli, Valeriana Cesarini, et al.
Pageof 2